Recovery Management Intervention in China

The purpose of the study is to develop and pilot-test a Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China.

The project has the following specific aims:

Primary aims:

Aim 1. To engage key stakeholders in the local communities involved in supporting the transition of heroin addicts released from compulsory rehabilitation to the community; Aim 2. To identify potential barriers for participating in MMT in China; Aim 3. To develop and deliver educational/training materials on HIV risks, relapse prevention, and MMT; Aim 4. To adapt and develop the Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China; Aim 5. To conduct a pilot trial and obtain preliminary outcome data associated with RMI, relative to enhanced standard care.

Secondary aim:

Aim 6. To explore predictors of relapse and HIV/AIDS risk behaviors.

It is hypothesized that the intervention will reduce drug use relapse and the negative consequences associated with relapse, including HIV risk behaviors

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Methadone Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Shanghai Mental Health Center

Shanghai, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The study population will be drawn from all adult patients at participating compulsory rehabilitation facilities who:

have been incarcerated for at least one year and would have been eligible for MMT at the time of incarceration,
have at least 1 month remaining before release,
met the DSM-IV criteria for heroin dependence at the time of incarceration,
are willing to enroll in methadone maintenance treatment, and
are Shanghai residents who reside in the areas of Shanghai targeted by the study.

Exclusion criteria

Individuals diagnosed with severe mental illness will not be eligible to participate.

Treatment and study plan

Recovery management

Behavioral

Sponsors and collaborators

Lead sponsor

University of California, Los Angeles

Other

Collaborators

National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Reducing HIV/AIDS and Drug Abuse Among Heroin Addicts Released From Compulsory Rehabilitation in China

Important dates

First posted: Jan 5, 2011
Registry last updated: Jan 5, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed